| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Galera Therapeutics, Inc. (GRTX) has 1 insider with recent SEC Form 4 filings, including 13 buys and 3 sells. GRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 195.0K | $19.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | Sorensen Mel | President And CEO | Sell | 70,000 | $0.02 | $1,407.00 | -26.4% | |
| Dec 30, 2024 | Chang Nancy T | - | Buy | 7,644,932 | $0.07 | $499,978.55 | New | |
| Aug 16, 2024 | Sorensen Mel | President And CEO | Sell | 67,015 | $0.07 | $4,825.08 | -20.2% | |
| Feb 8, 2024 | Schneid Yair | 10% Owner | Buy | 932,402 | $0.18 | $166,416.97 | +1.8% | |
| Mar 16, 2023 | Bachleda Mark | Chief Commercial Officer | Buy | 11,000 | $2.25 | $24,717.00 | New | |
| Mar 13, 2023 | Degnan Chris | Chief Financial Officer | Buy | 10,000 | $1.96 | $19,593.00 | New | |
| Mar 10, 2023 | Sorensen Mel | President And CEO | Buy | 100,000 | $1.68 | $168,120.00 | +43.1% | |
| Dec 17, 2021 | West Linda | Director | Buy | 20,000 | $2.74 | $54,804.00 | +50.0% | |
| Sep 1, 2021 | Holmlund Jon T | Chief Medical Officer | Sale+OE | 47,756 | $8.47 | $404,498.10 | -100% | |
| Jun 15, 2021 | West Linda | Director | Buy | 10,000 | $9.13 | $91,300.00 | +33.3% |